A. H. Partridge

475 total citations
17 papers, 155 citations indexed

About

A. H. Partridge is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. H. Partridge has authored 17 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. H. Partridge's work include Breast Cancer Treatment Studies (5 papers), Cancer survivorship and care (4 papers) and Cancer Treatment and Pharmacology (4 papers). A. H. Partridge is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Cancer survivorship and care (4 papers) and Cancer Treatment and Pharmacology (4 papers). A. H. Partridge collaborates with scholars based in United States and Canada. A. H. Partridge's co-authors include Eric P. Winer, Upendra Parvathaneni, Dagmar Amtmann, Fangxin Hong, William B. Lober, Nigel Bush, Jesse R. Fann, Seth Wolpin, Craig A. Bunnell and Rosemary Ford and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and American Journal of Ophthalmology.

In The Last Decade

A. H. Partridge

17 papers receiving 154 citations

Peers

A. H. Partridge

ONCOL

PHEOH

PPCH

PRM

Moira Rushton Canada

Deirdre Fitzpatrick United Kingdom

Yvonne van Riet Netherlands

Stephen Della‐Fiorentina Australia

Yu Ke Singapore

Omolara Fatiregun Nigeria

C. Farrell United Kingdom

Deena Graham United States

Patricia Bastick Australia

Julie Dean United States

Moira Rushton Canada

A. H. Partridge

129 ×1.1

ONCOL

35 ×1.0

28 ×0.9

PHEOH

15 ×0.6

PPCH

61 ×2.7

PRM

Citations per year, relative to A. H. Partridge A. H. Partridge (= 1×) peers Moira Rushton

Countries citing papers authored by A. H. Partridge

Since Specialization

Citations

This map shows the geographic impact of A. H. Partridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. H. Partridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. H. Partridge more than expected).

Fields of papers citing papers by A. H. Partridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. H. Partridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. H. Partridge. The network helps show where A. H. Partridge may publish in the future.

Co-authorship network of co-authors of A. H. Partridge

This figure shows the co-authorship network connecting the top 25 collaborators of A. H. Partridge. A scholar is included among the top collaborators of A. H. Partridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. H. Partridge. A. H. Partridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ligibel, JA, Anna Weiss, Tracy E. Crane, et al.. (2024). 1817MO Effect of a weight loss intervention (WLI) on exercise behaviors in women with breast cancer: Results from the breast cancer weight loss (BWEL) trial. Annals of Oncology. 35. S1078–S1078. 1 indexed citations

Berry, Donna L., Fangxin Hong, Barbara Halpenny, et al.. (2014). The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer. 14(1). 513–513. 52 indexed citations

Blinder, Victoria, N. W. Peacock, David P. Harrington, et al.. (2011). Patient perspectives on a treatment plan and summary program in community oncology care.. Journal of Clinical Oncology. 29(15_suppl). 6027–6027. 2 indexed citations

Cigler, Tessa, Jackie Szymonifka, A. H. Partridge, et al.. (2011). A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy.. Journal of Clinical Oncology. 29(15_suppl). 559–559. 1 indexed citations

Miller, Kurt W., Milan Radovich, Bradley A. Hancock, et al.. (2011). Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.. Journal of Clinical Oncology. 29(15_suppl). 1000–1000. 34 indexed citations

Ruddy, Kathryn J., Shari Gelber, Rulla M. Tamimi, et al.. (2011). Fertility concerns in young women with breast cancer: Results from a prospective cohort study.. Journal of Clinical Oncology. 29(15_suppl). 6025–6025. 3 indexed citations

Partridge, A. H., et al.. (2011). The ASCO Breast Cancer Registry pilot: Implementation of a multisite community practice registry and treatment plan/summary program.. Journal of Clinical Oncology. 29(15_suppl). 6101–6101. 4 indexed citations

Ruddy, Kathryn J., RM Tamimi, Lidia Schapira, et al.. (2010). Coping strategies in young women with breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 9159–9159. 2 indexed citations

Krop, Ian E., David Tuck, A. H. Partridge, et al.. (2010). Phase II trial of preoperative vinorelbine/trastuzumab (VH) or docetaxel/carboplatin/trastuzumab (TCH) in HER2-positive breast cancer with analysis of resistance mechanisms.. Journal of Clinical Oncology. 28(15_suppl). 549–549. 1 indexed citations

10.

Partridge, A. H., Richard L. Theriault, Douglas W. Blayney, et al.. (2010). The effect of age on delay in diagnosis and stage of breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 1580–1580. 1 indexed citations

11.

Ruddy, Kathryn J., Shari Gelber, Rulla M. Tamimi, et al.. (2009). Presentation of breast cancer in young women. Journal of Clinical Oncology. 27(15_suppl). 6608–6608. 8 indexed citations

12.

Ruddy, Kathryn J., A. H. Partridge, Lidia Schapira, et al.. (2008). Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Journal of Clinical Oncology. 26(15_suppl). 9571–9571. 1 indexed citations

13.

Muss, H. B., DA Berry, C. Cirrincione, et al.. (2008). Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907. Journal of Clinical Oncology. 26(15_suppl). 507–507. 19 indexed citations

14.

Partridge, A. H., Laura Archer, Alice B. Kornblith, et al.. (2008). CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907. Journal of Clinical Oncology. 26(15_suppl). 6542–6542. 6 indexed citations

15.

Partridge, A. H., et al.. (2005). Offering participants results of a clinical trial: sharing results of a negative study. American Journal of Ophthalmology. 139(6). 1153–1153. 3 indexed citations

16.

Partridge, A. H., et al.. (2005). Delayed premature menopause following chemotherapy for early stage breast cancer: Long-term results from IBCSG Trial V. Journal of Clinical Oncology. 23(16_suppl). 687–687. 5 indexed citations

17.

Partridge, A. H., Craig A. Bunnell, & Eric P. Winer. (2001). Quality of Life Issues Among Women Undergoing High-Dose Chemotherapy for Breast Cancer. Breast Disease. 14(1). 41–50. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact